Metraipolis › archive › dc_50ee741c54dd

Chondroitin Sulfate-Based Nanoplatforms: Advances and Challenges for Cancer Therapy — Europe PMC PMID:41471822

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41471822
DOI
10.3390/molecules30244798
License (as archived)
solo-consultazione
Archived
2026-11-07T14:39:55.640Z
SHA-256 of the archived text
963d810a045d917b5a3cc5ac1f6fd5d38e482d183777acaad54675d8b8005088
Stable URL of this page
https://metraipolis.com/documento/dc_50ee741c54dd

How to cite

Chondroitin Sulfate-Based Nanoplatforms: Advances and Challenges for Cancer Therapy — Europe PMC PMID:41471822 — Europe PMC (en), https://europepmc.org/article/MED/41471822 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_50ee741c54dd (Metraipolis archive dc_50ee741c54dd, sha256 963d810a045d917b5a3cc5ac1f6fd5d38e482d183777acaad54675d8b8005088)
BibTeX
@misc{dc50ee741c54dd,
  title = {Chondroitin Sulfate-Based Nanoplatforms: Advances and Challenges for Cancer Therapy — Europe PMC PMID:41471822},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41471822},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_50ee741c54dd; sha256 963d810a045d917b5a3cc5ac1f6fd5d38e482d183777acaad54675d8b8005088},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41471822. Agents can read the archived copy with the MCP tool read_document.